Stay updated on Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.

Latest updates to the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website footer’s software revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check18 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.4%

- Check25 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check53 days agoChange DetectedThe history table adds an entry for Revision: v3.7.0 and removes Revision: v3.6.6, reflecting an update to the page's revision-tracking rather than changes to the study data.SummaryDifference0.1%

- Check74 days agoChange DetectedThe history list now shows a new revision tag (v3.6.6) for the record, replacing the former v3.6.5 entry and indicating an update to the page’s version history.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.